Literature DB >> 4308600

Quantitative relationship of preexisting homotypic antibodies to excretion of poliovirus types 1, 2, and 3 following the feeding of trivalent attenuated poliovirus vaccine.

W P Glezen, R H McCollough, G A Lamb, T D Chin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4308600     DOI： 10.1093/oxfordjournals.aje.a121058

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  8 in total

1.  Trends in the risk of U.S. polio outbreaks and poliovirus vaccine availability for response.

Authors:  Kimberly M Thompson; Gregory S Wallace; Radboud J Duintjer Tebbens; Philip J Smith; Albert E Barskey; Mark A Pallansch; Kathleen M Gallagher; James P Alexander; Gregory L Armstrong; Stephen L Cochi; Steven G F Wassilak
Journal:  Public Health Rep       Date:  2012 Jan-Feb       Impact factor: 2.792

2.  The response to oral poliovaccine in persons aged 16-18 years.

Authors:  J W Smith; J A Lee; W B Fletcher; C A Morris; D A Parker; R Yetts; D I Magrathe; F T Perkins
Journal:  J Hyg (Lond)       Date:  1976-04

Review 3.  Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs.

Authors:  Radboud J Duintjer Tebbens; Mark A Pallansch; Konstantin M Chumakov; Neal A Halsey; Tapani Hovi; Philip D Minor; John F Modlin; Peter A Patriarca; Roland W Sutter; Peter F Wright; Steven G F Wassilak; Stephen L Cochi; Jong-Hoon Kim; Kimberly M Thompson
Journal:  Risk Anal       Date:  2013-03-28       Impact factor: 4.000

4.  Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.

Authors:  Michael Famulare; Stewart Chang; Jane Iber; Kun Zhao; Johnson A Adeniji; David Bukbuk; Marycelin Baba; Matthew Behrend; Cara C Burns; M Steven Oberste
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

5.  Antigenic sequences of poliovirus recognized by T cells: serotype-specific epitopes on VP1 and VP3 and cross-reactive epitopes on VP4 defined by using CD4+ T-cell clones.

Authors:  B P Mahon; K Katrak; K H Mills
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

6.  Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP): Recommended Immunization Schedule (2020-21) and Update on Immunization for Children Aged 0 Through 18 Years.

Authors:  Srinivas G Kasi; S Shivananda; Sanjay Marathe; Kripasindhu Chatterjee; Sunil Agarwalla; Shashi Kant Dhir; Sanjay Verma; Abhay K Shah; Sanjay Srirampur; Srinivas Kalyani; Harish Kumar Pemde; S Balasubramanian; Bakul J Parekh; G V Basavaraja; Piyush Gupta
Journal:  Indian Pediatr       Date:  2021-11-29       Impact factor: 1.411

Review 7.  Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame.

Authors:  Edward Pk Parker; Natalie A Molodecky; Margarita Pons-Salort; Kathleen M O'Reilly; Nicholas C Grassly
Journal:  Expert Rev Vaccines       Date:  2015-07-09       Impact factor: 5.217

8.  The potential impact of expanding target age groups for polio immunization campaigns.

Authors:  Radboud J Duintjer Tebbens; Dominika A Kalkowska; Steven G F Wassilak; Mark A Pallansch; Stephen L Cochi; Kimberly M Thompson
Journal:  BMC Infect Dis       Date:  2014-01-29       Impact factor: 3.090
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.